Torrent Pharmaceuticals has received shareholders' nod to raise up to Rs 5,000 crore through issuance of equity shares including convertible bonds/debentures through QIP and/or depository receipts or any other modes for an amount not exceeding Rs 5,000 crore. The approval of the shareholders was sought by way of special resolution through a postal ballot.
Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
